A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder

2010 ◽  
Vol 184 (2) ◽  
pp. 616-622 ◽  
Author(s):  
Tara L. Frenkl ◽  
Haiyuan Zhu ◽  
Theodore Reiss ◽  
Olga Seltzer ◽  
Elizabeth Rosenberg ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Receptor Antagonist ◽  
Controlled Trial ◽  
Double Blind ◽  
Neurokinin 1 Receptor ◽  
Neurokinin 1

scholarly journals A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial

2011 ◽  
Vol 21 (3) ◽  
pp. 221-229 ◽  
Author(s):  
Sanjay J. Mathew ◽  
Meena Vythilingam ◽  
James W. Murrough ◽  
Carlos A. Zarate ◽  
Adriana Feder ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Proof Of Concept ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Neurokinin 1 Receptor ◽  
Chronic Ptsd ◽  
Neurokinin 1

Efficacy and safety of repeated dosing of netupitant, a neurokinin-1 receptor antagonist, in treating overactive bladder

2013 ◽  
Vol 33 (3) ◽  
pp. 335-340 ◽  
Author(s):  
F. Haab ◽  
B. Braticevici ◽  
G. Krivoborodov ◽  
M. Palmas ◽  
M. Zufferli Russo ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Receptor Antagonist ◽  
Efficacy And Safety ◽  
Neurokinin 1 Receptor ◽  
Repeated Dosing ◽  
Neurokinin 1
Sign in / Sign up

Export Citation Format

Share Document